4.6 Article

Cationic polypeptides are required for antibacterial activity of human airway fluid

Journal

JOURNAL OF IMMUNOLOGY
Volume 169, Issue 12, Pages 6985-6991

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.169.12.6985

Keywords

-

Categories

Funding

  1. NHLBI NIH HHS [HL70876] Funding Source: Medline
  2. NIAID NIH HHS [AI48167] Funding Source: Medline
  3. PHS HHS [02878, 12878, 13948, 016692] Funding Source: Medline

Ask authors/readers for more resources

In a search for direct evidence leading to the biological relevance of airway secretions in innate host defense, we characterized the antibacterial function of cationic polypeptides within minimally manipulated nasal fluid. In this study, we show that cationic antimicrobial polypeptides are responsible for most of the bactericidal activity of whole nasal fluid. The removal of cationic polypeptides using a cation-exchange resin ablated the activity of nasal fluid against Escherichia coli, Listeria monocytogenes, and Pseudomonas aeruginosa. By using a novel proteomic approach, we identified a dozen cationic peptides and proteins within nasal fluid, all of which either are known antimicrobial polypeptides or have other proposed roles in host defense. Of the three most abundant cationic polypeptides in nasal fluid, lysozyme was more effective than either lactoferrin or secretory leukoprotease inhibitor in restoring the antibacterial activity of the cationic polypeptide-depleted fluid against a mucoid cystic fibrosis isolate of P. aeruginosa.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available